2014 Q3 Form 10-Q Financial Statement

#000119312514409297 Filed on November 12, 2014

View on sec.gov

Income Statement

Concept 2014 Q3 2013 Q3
Revenue $31.54M $26.31M
YoY Change 19.89% -21.07%
Cost Of Revenue $29.12M $25.23M
YoY Change 15.42% -14.63%
Gross Profit $2.421M $1.078M
YoY Change 124.59% -71.46%
Gross Profit Margin 7.67% 4.1%
Selling, General & Admin $1.297M $1.046M
YoY Change 24.02% -20.94%
% of Gross Profit 53.57% 97.01%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $450.0K $450.0K
YoY Change 0.0% 0.0%
% of Gross Profit 18.59% 41.75%
Operating Expenses $1.297M $1.046M
YoY Change 24.02% -20.94%
Operating Profit $1.124M $407.0K
YoY Change 176.19% -86.48%
Interest Expense $20.00K $20.00K
YoY Change 0.0% 0.0%
% of Operating Profit 1.78% 4.91%
Other Income/Expense, Net $0.00 $0.00
YoY Change
Pretax Income $1.139M $47.76K
YoY Change 2285.74% -98.07%
Income Tax $373.7K $20.10K
% Of Pretax Income 32.8% 42.08%
Net Earnings $765.7K $27.66K
YoY Change 2668.19% -98.32%
Net Earnings / Revenue 2.43% 0.11%
Basic Earnings Per Share $0.11 $0.00
Diluted Earnings Per Share $0.11 $0.00
COMMON SHARES
Basic Shares Outstanding 6.799M 6.799M shares
Diluted Shares Outstanding 6.799M 6.799M shares

Balance Sheet

Concept 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.230M $13.98M
YoY Change -48.28% -32.4%
Cash & Equivalents $7.228M $13.98M
Short-Term Investments
Other Short-Term Assets $357.5K $357.9K
YoY Change -0.11% 19.29%
Inventory $40.05M $39.50M
Prepaid Expenses
Receivables $8.063M $7.528M
Other Receivables $0.00 $0.00
Total Short-Term Assets $55.69M $61.36M
YoY Change -9.24% -3.36%
LONG-TERM ASSETS
Property, Plant & Equipment $14.40M $10.52M
YoY Change 36.93% -10.87%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $1.110M $1.040M
YoY Change 6.73% 6.12%
Total Long-Term Assets $15.51M $11.56M
YoY Change 34.12% -9.53%
TOTAL ASSETS
Total Short-Term Assets $55.69M $61.36M
Total Long-Term Assets $15.51M $11.56M
Total Assets $71.20M $72.93M
YoY Change -2.37% -4.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.420M $7.880M
YoY Change -31.22% 0.13%
Accrued Expenses $700.0K $550.0K
YoY Change 27.27% -35.29%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.339M $9.006M
YoY Change -29.61% -6.18%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.050M $980.0K
YoY Change 7.14% 8.89%
Total Long-Term Liabilities $1.050M $980.0K
YoY Change 7.14% 8.89%
TOTAL LIABILITIES
Total Short-Term Liabilities $6.339M $9.006M
Total Long-Term Liabilities $1.050M $980.0K
Total Liabilities $7.520M $10.22M
YoY Change -26.42% -6.24%
SHAREHOLDERS EQUITY
Retained Earnings $32.18M $31.20M
YoY Change 3.14%
Common Stock $36.98M $36.98M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.476M $5.476M
YoY Change 0.0%
Treasury Stock Shares 1.176M shares 1.176M shares
Shareholders Equity $63.69M $62.71M
YoY Change
Total Liabilities & Shareholders Equity $71.20M $72.93M
YoY Change -2.37% -4.4%

Cashflow Statement

Concept 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income $765.7K $27.66K
YoY Change 2668.19% -98.32%
Depreciation, Depletion And Amortization $450.0K $450.0K
YoY Change 0.0% 0.0%
Cash From Operating Activities $0.00 -$2.920M
YoY Change -100.0% -137.58%
INVESTING ACTIVITIES
Capital Expenditures -$3.410M -$140.0K
YoY Change 2335.71% 180.0%
Acquisitions
YoY Change
Other Investing Activities -$10.00K -$10.00K
YoY Change 0.0% -50.0%
Cash From Investing Activities -$3.420M -$150.0K
YoY Change 2180.0% 150.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -130.0K -550.0K
YoY Change -76.36% -38.2%
NET CHANGE
Cash From Operating Activities 0.000 -2.920M
Cash From Investing Activities -3.420M -150.0K
Cash From Financing Activities -130.0K -550.0K
Net Change In Cash -3.550M -3.620M
YoY Change -1.93% -153.08%
FREE CASH FLOW
Cash From Operating Activities $0.00 -$2.920M
Capital Expenditures -$3.410M -$140.0K
Free Cash Flow $3.410M -$2.780M
YoY Change -222.66% -135.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
543956
CY2013Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13980750
CY2014Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6799444 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7975160 shares
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2014Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1175716 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
6339173
CY2014Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
542061
CY2014Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
135989
CY2014Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7975160 shares
CY2014Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2014Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
1175716 shares
CY2014Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29822301
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
63686083
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29003674
CY2014Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
5424514
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
32183213
CY2014Q3 us-gaap Deferred Compensation Cash Based Arrangements Liability Current
DeferredCompensationCashBasedArrangementsLiabilityCurrent
157500
CY2014Q3 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
1051472
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
7975160
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
71201761
CY2014Q3 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
125033
CY2014Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
79109
CY2014Q3 us-gaap Land
Land
1410689
CY2014Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8063309
CY2014Q3 us-gaap Inventory Net
InventoryNet
40046075
CY2014Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
35076653
CY2014Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5475964
CY2014Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
14401750
CY2014Q3 us-gaap Assets
Assets
71201761
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7227665
CY2014Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
7736709
CY2014Q3 us-gaap Other Assets Current
OtherAssetsCurrent
357462
CY2014Q3 us-gaap Assets Current
AssetsCurrent
55694511
CY2014Q3 frd Cash Value Of Officers Life Insurance And Other Assets Non Current
CashValueOfOfficersLifeInsuranceAndOtherAssetsNonCurrent
1105500
CY2014Q3 frd Allowance For Doubtful Accounts Receivable And Cash Discounts Current
AllowanceForDoubtfulAccountsReceivableAndCashDiscountsCurrent
32276
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15923294
CY2014Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2014Q1 us-gaap Liabilities Current
LiabilitiesCurrent
7770689
CY2014Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
375860
CY2014Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
135989
CY2014Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28934601
CY2014Q1 us-gaap Stockholders Equity
StockholdersEquity
63310656
CY2014Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
29003674
CY2014Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7206340
CY2014Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
31807786
CY2014Q1 us-gaap Deferred Compensation Cash Based Arrangements Liability Current
DeferredCompensationCashBasedArrangementsLiabilityCurrent
52500
CY2014Q1 us-gaap Other Postretirement Defined Benefit Plan Liabilities Noncurrent
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
1013056
CY2014Q1 us-gaap Common Stock Value
CommonStockValue
7975160
CY2014Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
72284399
CY2014Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
189998
us-gaap Net Income Loss
NetIncomeLoss
836018
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
278444
us-gaap Cost Of Goods Sold
CostOfGoodsSold
52370754
CY2014Q1 us-gaap Land
Land
1410689
CY2014Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
9347289
CY2014Q1 us-gaap Inventory Net
InventoryNet
35288559
CY2014Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
31773161
CY2014Q1 us-gaap Treasury Stock Value
TreasuryStockValue
5475964
CY2014Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11362731
CY2014Q1 us-gaap Assets
Assets
72284399
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15081024
CY2014Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
7113482
CY2014Q1 us-gaap Other Assets Current
OtherAssetsCurrent
129796
CY2014Q1 us-gaap Assets Current
AssetsCurrent
59846668
CY2014Q1 frd Cash Value Of Officers Life Insurance And Other Assets Non Current
CashValueOfOfficersLifeInsuranceAndOtherAssetsNonCurrent
1075000
CY2014Q1 frd Allowance For Doubtful Accounts Receivable And Cash Discounts Current
AllowanceForDoubtfulAccountsReceivableAndCashDiscountsCurrent
27276
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6799444 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-670613
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6799444 shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
153019
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
31000
us-gaap Income Taxes Paid
IncomeTaxesPaid
551000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
254311
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1087912
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
55892512
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1202206
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1509086
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Interest And Other Income
InterestAndOtherIncome
31007
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1087912
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-125991
us-gaap Costs And Expenses
CostsAndExpenses
54721313
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-141669
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-1942544
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
34954
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-184019
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2350559
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
366188
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
492179
us-gaap Depreciation
Depreciation
913800
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3301269
frd Increase Decrease In Deferred Compensation Cash Based Arrangements Liability
IncreaseDecreaseInDeferredCompensationCashBasedArrangementsLiability
105000
frd Increase Decrease In Deferred Credit For Lifo Inventory Replacement Cost
IncreaseDecreaseInDeferredCreditForLifoInventoryReplacementCost
32213
dei Trading Symbol
TradingSymbol
FRD
dei Entity Registrant Name
EntityRegistrantName
FRIEDMAN INDUSTRIES INC
dei Amendment Flag
AmendmentFlag
false
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Document Type
DocumentType
10-Q
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Entity Central Index Key
EntityCentralIndexKey
0000039092
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3926719
us-gaap Payments To Acquire Life Insurance Policies
PaymentsToAcquireLifeInsurancePolicies
30500
us-gaap Income Taxes Paid
IncomeTaxesPaid
278000
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.04
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6799444 shares
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3624162
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6799444 shares
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
227666
CY2013Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2013Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2013Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.08
CY2013Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6799444 shares
us-gaap Interest And Other Income
InterestAndOtherIncome
30534
us-gaap Net Income Loss
NetIncomeLoss
647405
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4757516
us-gaap Cost Of Goods Sold
CostOfGoodsSold
55986005
CY2013Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6799444 shares
CY2013Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
26310369
CY2013Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
47757
CY2013Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
15500
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
27659
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
271978
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
59448996
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1062096
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1283980
us-gaap Interest Paid Net
InterestPaidNet
0
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-271978
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-64965
us-gaap Costs And Expenses
CostsAndExpenses
58417434
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
166201
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-7853359
us-gaap Pension And Other Postretirement Benefit Expense
PensionAndOtherPostretirementBenefitExpense
38416
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3957219
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2431429
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
414691
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
79109
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
479656
us-gaap Depreciation
Depreciation
887700
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1781826
frd Increase Decrease In Deferred Compensation Cash Based Arrangements Liability
IncreaseDecreaseInDeferredCompensationCashBasedArrangementsLiability
105000
CY2013Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
25232456
CY2013Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-23145
CY2013Q3 us-gaap Costs And Expenses
CostsAndExpenses
26278112
CY2013Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1045656
CY2013Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20098
CY2013Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
43243
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.02
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6799444 shares
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6799444 shares
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
31544474
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
1139359
CY2014Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
15282
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
765655
CY2014Q3 us-gaap Cost Of Goods Sold
CostOfGoodsSold
29123545
CY2014Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-27517
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
30420397
CY2014Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1296852
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
373704
CY2014Q3 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
401221

Files In Submission

Name View Source Status
0001193125-14-409297-index-headers.html Edgar Link pending
0001193125-14-409297-index.html Edgar Link pending
0001193125-14-409297.txt Edgar Link pending
0001193125-14-409297-xbrl.zip Edgar Link pending
d804584d10q.htm Edgar Link pending
d804584dex311.htm Edgar Link pending
d804584dex312.htm Edgar Link pending
d804584dex321.htm Edgar Link pending
d804584dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
frd-20140930.xml Edgar Link completed
frd-20140930.xsd Edgar Link pending
frd-20140930_cal.xml Edgar Link unprocessable
frd-20140930_def.xml Edgar Link unprocessable
frd-20140930_lab.xml Edgar Link unprocessable
frd-20140930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending